Dr. Matthew “Oki” O’Connor in Berlin at Undoing Aging 2019

Underdog Pharmaceuticals Announces MD.USE Partnership and Technology Acquisition

Underdog Pharmaceuticals June 12, 2020

Underdog Pharmaceuticals Announces MD.USE Partnership and Technology Acquisition MOUNTAIN VIEW, Calif., Jun. 12, 2020 — Underdog Pharmaceuticals, Inc., a pharmaceutical company designing engineered cyclodextrins to address atherosclerosis and other serious diseases of aging, has completed

7-Ketocholesterol in disease and aging

Underdog Pharmaceuticals February 4, 2020

Scientists from Underdog Pharmaceuticals, in conjunction with Professor Jay Jerome of Vanderbilt University Medical Center, have published an article in the journal Redox Biology, covering the role of the toxic biomolecule 7-ketocholesterol, especially in the

Kizoo Technology Capital leads seed round financing at Underdog Pharmaceuticals

Underdog Pharmaceuticals November 14, 2019

Kizoo Technology Capital leads seed round financing at Underdog Pharmaceuticals SRF announces leadership appointments MOUNTAIN VIEW, Calif., Nov. 14, 2019 (GLOBE NEWSWIRE) — Underdog Pharmaceuticals, Inc. (Underdog), and SENS Research Foundation (SRF) today announced the launch